The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma
ConditionPseudoexfoliation Glaucoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorVance Thompson Vision
About this trial
Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.
Eligibility criteria
Qualifiers
Adult patients diagnosed with pseudoexfoliation glaucoma (PXFG), with optic neuropathy consistent with glaucomatous damage of any severity
Open iridocorneal angle by gonioscopy, defined as a Shafer Grade II or greater
Treatment naive, or washed out IOP ranging from ≥18-35 mmHg
Able to complete medication washout safely and all follow-up visits
Disqualifiers
Any contraindication to SLT or unable to have DSLT
Angle closure glaucoma or any other types of glaucoma other than PXFG
Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye
Any prior refractive surgery
Trial design
Treatments tested in this trial
- Direct selective laser trabeculoplasty
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov